Symbol
SLXN on Nasdaq
Investment type
Equity - Shares of Stock
Class
Ordinary Shares, par value $0.0009 per share
Latest Disclosed Ownership
112K shares
Security Ownership
6.6%

THE GOLDMAN SACHS GROUP, INC. ownership in Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN)

2025-02-10 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 112K shares of Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN). This represents 6.6% percent ownership of the company.